Research
Stanford researcher uses AI to identify existing drugs for liver fibrosis
A Stanford geneticist deployed Google DeepMind's Co-Scientist to screen existing medicines for potential liver fibrosis treatments, demonstrating how AI can accelerate drug repurposing in chronic disease research.
1 min read
SourceGoogle DeepMind Blog
A Stanford geneticist has used Google DeepMind's Co-Scientist AI system to identify candidate medicines for treating liver fibrosis, a progressive scarring condition that affects millions globally. The work shows how large language models paired with domain expertise can compress months of literatur...
Sign in to read the full analysis
Free — just an email. Get full analysis on LLM unit economics, plus the weekly Cost-of-Inference column.
Method & sources
- Source type
- Primary publication (lab/vendor blog) — our analysis + implication
- Source link
- Google DeepMind Blog
- Published
- UTC
- Byline
- By the gotcontext.ai team (editorial standards)
- Correction?
- corrections@gotcontext.ai